The Classic Egg-Yolk Macular Dystrophy of Childhood
The name gives it away the moment you look at a retinal photograph: a round, yellow, egg-yolk-like deposit sitting directly beneath the macula — vitelliform, from the Latin for egg-yolk. Best disease moves through a fairly predictable sequence of stages as that deposit forms, breaks apart, and eventually resolves, and it is this staged pattern, more than any single symptom, that guides how the condition is followed over time.
One detail surprises most Nigerian families at their first visit: a child can have a strikingly visible yolk-like lesion on examination while still reading perfectly well. Vision and lesion appearance do not always move together, which is exactly why staging the disease correctly matters more than reacting to how dramatic the retinal photograph looks.
In the earliest, classic "egg-yolk" stage, central vision is often only mildly affected or entirely normal, even though the lesion itself is clearly visible on examination. Symptoms tend to emerge once the lesion enters the "scrambled-egg" or vitelliruptive stage, when the once-uniform deposit begins to break apart — this is when blurred or distorted central vision, along with difficulty reading fine print, usually becomes noticeable. In later atrophic stages, central vision loss becomes more established, and in a minority of cases abnormal blood vessel growth beneath the retina can cause a sudden further drop.
Best disease is caused by mutations in the BEST1 gene, which produces a protein called bestrophin-1 that helps regulate ion and fluid movement across the retinal pigment epithelium. When that regulation fails, fluid and pigment accumulate abnormally beneath the macula, forming the vitelliform lesion. Inheritance is autosomal dominant, though expressivity varies considerably — some gene carriers show a visible lesion with barely any symptoms, while others in the same family experience more significant vision changes.
The electro-oculogram, or EOG, is the single most distinctive test here — Best disease produces a strikingly abnormal Arden ratio even in eyes where the ERG looks essentially normal, and that particular combination is what sets it apart from other vitelliform-appearing conditions. OCT is used to stage exactly how the lesion is evolving, and genetic testing for BEST1 confirms the diagnosis and helps identify which additional family members may be carriers.
Because the disease genuinely can remain stable for years at a time, much of the early management is careful staged monitoring rather than immediate intervention, with particular attention paid to the small risk of abnormal vessel growth as the lesion evolves. For patients whose vision has become meaningfully affected, regenerative stem cell therapy is evaluated as part of a broader plan aimed at protecting whatever central function remains.
Yes, this is a genuinely common and expected pattern in the early vitelliform stage of Best disease. The size of the lesion on a photograph does not directly predict how well someone can see, which is why staging the disease properly matters more than reacting to the appearance alone.
No — Best disease is a localised, benign condition confined to the retina and is not related to cancer in any way. It can, however, evolve through several distinct stages over time, which is exactly what ongoing monitoring is designed to track.
This comes down to variable expressivity — a hallmark feature of BEST1 mutations. Your brother may well carry the same faulty gene yet show little to no visible lesion or symptoms, rather than having genuinely skipped the condition, so testing him directly is the only way to know for certain.
Not always — a meaningful number of patients remain stable with good central vision for many years, particularly if the lesion stays in its earlier stages. That said, because the course does vary, ongoing monitoring remains the safest way to catch any change early.